Filing Flows › Comparisons › CAMP vs RANI
Camp4 Therapeutics vs Rani Therapeutics Holdings: CAMP and RANI compared
Camp4 Therapeutics is the larger company: $1.9M of revenue in its latest quarter (Q3 2026) against $1.7M for Rani Therapeutics Holdings (Q2 2026). Rani Therapeutics Holdings is more profitable, with an operating margin of -516.9% against -738.8%.
Where the money goes: CAMP and RANI
Camp4 Therapeutics (CAMP) · Q3 2026
Camp4 Therapeutics, Q3 2026: revenue $1.9M (+139% year over year), operating margin -738.8%, net loss $29.0M, operating cash flow −$8.2M. The chart follows the revenue to costs, profit and cash.
Rani Therapeutics Holdings (RANI) · Q2 2026
Rani Therapeutics Holdings, Q2 2026: revenue $1.7M, operating margin -516.9%, net loss $8.4M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.
| Camp4 Therapeutics (CAMP) | Rani Therapeutics Holdings (RANI) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $1.9M | $1.7M |
| Revenue growth, Y/Y | +139% | — |
| Operating margin | -738.8% | -516.9% |
| Net earnings | −$29.0M | −$8.4M |
| Net margin | — | -493.0% |
| Operating cash flow | −$8.2M | −$9.0M |
Questions
Which is bigger, Camp4 Therapeutics or Rani Therapeutics Holdings?
Camp4 Therapeutics is the larger company: $1.9M of revenue in its latest quarter (Q3 2026) against $1.7M for Rani Therapeutics Holdings (Q2 2026).
Is Camp4 Therapeutics or Rani Therapeutics Holdings growing faster?
Rani Therapeutics Holdings is more profitable, with an operating margin of -516.9% against -738.8%.
More: Camp4 Therapeutics earnings · how Camp4 Therapeutics makes money · Rani Therapeutics Holdings earnings · how Rani Therapeutics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.